Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 6Phase 1/2 3Phase NA 2Phase 2/3 2Phase 1 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Esophageal Squamous Cell Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Vomiting 1Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Pancreatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Nausea 1Lung Neoplasms 1Klatskin Tumor 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1Adenocarcinoma Of Esophagus 1

Interventions

Paclitaxel 10Radiotherapy 7Fluorouracil 7pembrolizumab 6Carboplatin 6Oxaliplatin 5Cisplatin 5lenvatinib 3Neoadjuvant Therapy 3Cetuximab 3tislelizumab 2camrelizumab 2Surgical Procedures, Operative 2Nivolumab 2Leucovorin 2Irinotecan 2Drug Therapy 2Docetaxel 2tremelimumab 1toripalimab 1regorafenib 1osimertinib 1oblimersen 1nimotuzumab 1nedaplatin 1monalizumab 1enzalutamide 1durvalumab 1aflibercept 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Esophageal Squamous Cell Carcinoma × Neoadjuvant Therapy × Clear all
NCT07385001 2026-02-03

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Tang-Du Hospital

Phase 1/2 Recruiting
45 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT00093652 2015-10-06

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Roswell Park Cancer Institute

Phase 1/2 Terminated
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00425425 2014-05-01

Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer

Technical University of Munich

Phase 1/2 Unknown
43 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡